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Abstract
Tuberculosis (TB) is a leading cause of human mortality due to infectious
disease. Treatment default is a relevant factor which reduces therapeutic suc-
cess and increases the risk of resistant TB. In this work we analyse the relation
between treatment default and treatment length along with its consequence
on the disease spreading. We use a stylized model structure to explore, sys-
tematically, the effects of varying treatment duration and compliance. We
find that shortening treatment alone may not reduce TB prevalence, espe-
cially in regions where transmission intensity is high, indicating the necessity
of complementing this action with increased compliance. A family of default
functions relating the proportion of defaulters to the treatment length is con-
sidered and adjusted to a particular dataset. We find that the epidemiological
benefits of shorter treatment regimens are tightly associated with increases
in treatment compliance and depend on the epidemiological background.
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1. Introduction
Tuberculosis (TB), a communicable disease transmitted byMycobacterium
tuberculosis (Mtb), is the second leading cause of death worldwide [1], with
approximately two million deaths per year around the world. The basis of
the World Health Organization (WHO) TB control programs recommends a
treatment strategy that consists on a 6- to 8-month regimen, termed directly
observed treatment (DOTS) [2]. Treatment default remains a challenge to
the success of this strategy, contributing to treatment failure and increasing
the risk of multidrug-resistant TB [3]. Under DOTS programs, the propor-
tion of individuals dropping out of treatment can range from 6% to 30%
[4, 5], with available data indicating that defaulters more often leave treat-
ment in its later stages [4]. Current thesis asserts that an improvement of
the patient health conditions soon after treatment initiation associated with
long treatment duration is an important cause of default. Because of this,
some efforts have been placed to reduce the length of treatment based on
new short-term efficient drugs [6, 7].
Mathematical models have been proposed to analyse the effect of novel
therapies with the focus on treatment shortening, taking into account treat-
ment default [8, 9, 10]. However, the relation between treatment length and
proportion of defaulters, and its impact on disease spreading has not been
fully addressed in these models.
In this work we focus on the influence of treatment length and treatment
default on TB dynamics and on the possible relation between these two pro-
cesses. We assume that individuals while in treatment cannot be reinfected
and do not contribute to disease spread. This leads to a conflicting situation
whereby shortening treatment is beneficial to TB control due to reduction
in default while, simultaneously, it reduces the time during which individu-
als are protected against subsequent reinfections. Whether the net effect is
beneficial or detrimental is the question that we address herein by means of
mathematical models.
This study is systematized by first analyzing the impact of shortening
treatment independently of changes in the proportion of default, and then
recognizing that variations in treatment length can also induce a change in
treatment adherence and analyzing the combined effects of both changes.
There are many works reporting data on TB treatment default, but just a
few in relation to treatment shortening. Examples include timing of default
for cities in 10 countries [4], default after re-treatment in India (2006) [11],
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factors predicting treatment adherence in Southern Ethiopia (2002-2004) [3],
and default during diagnosis in Pakistan (2008) [12]. TB compliance is a com-
plex multifactorial phenomenon that has motivated many qualitative studies
compiled in review articles, e.g. [13]. Quantitative studies are fewer and in-
clude the analysis of TB default in Uzbekistan (2005) [14] and in the Nether-
lands (1993-1997) [15]. These data are typically analyzed by calculating the
cumulative probability of non-adherence using Kaplan-Meier survival curves.
However, the rate of defaults over time has limited information regarding the
effect of treatment length on the rate of default. TB surveillance systems that
are in place in many countries are likely to contain this information.
Surveillance data on TB in Portugal for the period of 2002-2009 was
provided by the Portuguese National Directorate of Health (Portuguese TB
Surveillance System – SVIG-TB). These data, collected by medical practi-
tioners, consists of predicted treatment length, varying from 2 to 12 months,
and treatment outcome of well-identified patients, which distinguishes the
following possibilities: i) treatment completed, with or without laboratory
confirmation; ii) treatment failure; iii) treatment default, i.e., lost to follow
up; iv) death from tuberculosis or other causes. From the comparison of
default rates for different predicted treatment lengths, we can analyze the
dependence between these variables. Although available information on the
interdependency between default rates and treatment lengths is restricted
to three different durations (2, 6 and 12 months), the data consistently in-
dicates an inverse relationship between these quantities. Therefore we set
up a family of default functions capable of describing this trend. Function
paramaters are estimated by fitting to the Portuguese data. The function is
then introduced into a TB transmission model to assess the epidemiological
consequences of the estimated relation.
In contrast to other models [8, 9, 10], we use a minimal mathematical
model with few compartments and parameters. Aspects that are mainly im-
portant when TB dynamics are confronted with data for structured popula-
tions (such as age, gender, social conditions) or other epidemiological aspects
(such as smear status) are not detailed herein. We discuss how changes in
treatment protocols might impact the dynamics of TB, considering both TB
prevalence (proportion of infectious individuals) and the basic reproductive
number R0 as outcomes. We report results for a wide range of contact rates
and focus on general trends, hoping to motivate future research to assess
specific settings in more detail conditional to data availability.
This work is organized as follows: In Section 2 we introduce the model, in
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context with others in the literature: in Subsection 2.1 we present the system
of nonlinear differential equations, and the model is analyzed in Subsection
2.2. In Section 3, the results are presented in terms of the impact of reducing
treatment length on TB prevalence and on R0: in Subsection 3.1 the default
and treatment length are independent from each other; in Subsection 3.2
we consider a family of functions that couples default and treatment length.
Finally, in Section 4, we present the discussion and concluding remarks.
2. Tuberculosis transmission and treatment model
The mathematical model for TB transmission considered herein extends
the well known SIR and SIS systems by incorporating latency, the effect of
treatment, dropout from it (treatment default), and reinfection with partial
immunity. Our purpose is to describe the non-negligible treatment default
that is relevant in some already quoted regions of the world [4], together with
the processes of relapse and reinfection.
We chose a minimal model, that is able to take into account the quoted
effects, with five distinct compartments, which correspond to proportions of
the population in the following groups:
S - Susceptible: individuals that have never been in contact with Mtb.
P - Primary: individuals that have been infected by Mtb but for whom
disease progression is still uncertain.
L - Latent: infected individuals that have contained the infection and
remain latent.
I - Infectious: individuals that have progressed to active TB and are not
yet in treatment.
T - Under Treatment: individuals that presented active TB and are cur-
rently submitted to treatment.
The dynamics of transitions among these compartments are based on the
following assumptions, as illustrated by a diagram in Figure 1:
a - All individuals have the same death rate µ except for I individuals who,
in general, may suffer additional TB-related mortality, this is µI ≥ µ.
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b - S individuals become P infected due to the contact between S and
I individuals with effective contact rate β. To keep the population
constant in time, the birth rate compensates deaths b = µ(1−I)+µII.
c - P state results from the contact process described above, but also from
the contact between L and I individuals with rate σβ due to reinfection,
where σ ∈ [0, 1] refers to partial protection to reinfection. We assume
that P individuals are not infectious. A fraction φ of individuals in
P progress to active disease and the remaining consolidate as latently
infected, at rates δφ and δ(1− φ), respectively.
d - L individuals are latently infected. They are able to contain infection,
whether this has never taken the form of active disease or has been
active and cured, either self-cured directly from class I at rate τSC or
after successful treatment. Besides the reinfection process described
before, L individuals are subject to relapse at a constant rate ω.
e - I individuals are responsible for the disease spreading. They have active
disease requiring treatment to reestablish normal health conditions. We
assume that I individuals can leave the compartment when no longer
spread disease, after being detected and start treatment to class T at
a constant rate τ , or by self-cure at a constant rate τSC to class L.
f - Individuals in class T are under treatment. They no longer contribute
to disease spread and are protected from reinfection. Individuals leave
this compartment at rate δT , depending on treatment outcome: a pro-
portion φT defaults back to the infectious state and the remaining
progress to the latent state as a result of successful treatment.
These assumptions are formalized by a system of ordinary differential






























= µ(1− I) + µII − βIS − µS
dP
dt
= βI(S + σL)− (δ + µ)P
dL
dt
= (1− φ)δP + (1− φT )δTT + τSCI − σβIL− (ω + µ)L
dI
dt
= φδP + ωL+ φT δTT − (τ + τSC + µI)I
dT
dt
= τI − (δT + µ)T
. (1)
The proposed model is derived from a previous formulation [16], with
modifications as follows. In order to address specifically treatment length
and default we introduce compartment T in the current model to repre-
sent individuals undergoing treatment. Furthermore, we do not consider any
treatment actions for P and L individuals, as we are not assessing the effect
of latent treatment in this study. Note that, as before, we assume that even
the patients that conclude treatment and become cured are considered to
be latent L, since Mtb is not completely eliminated from the organism [17].
It is important to note the distinction between relapse and reinfection: the
first process is described by a direct transition from L to I at a constant
rate, while the second it is proportional to βI and it requires a first transi-
tion to class P where it follows the same dynamics used to describe the new
infections.
A specificity of this model is that patients, while in treatment (on class
T), are neither infectious nor subject to reinfection. Hence, class T acts as a
protected class when compared to the others. Previous models have different
assumptions, considering that individuals under treatment can be partially
infectious [8] or can be subject to reinfection at a reduced rate [9]. Our
assumption can be relaxed to include these cases, as we comment on these
model differences and their consequences in forthcoming sections. Another
distinguishing feature of our model is to formulate the average treatment du-
ration (1/δT ) independently of the proportion of treatment defaulters (φT ),
while the average time spent in treatment (class T) is different for defaulters
(1/φT δT ) and successfully treated individuals (1/(1 − φT )δT ). This allows
us to explore the consequences of changing independently the recommended
duration of treatment and the fraction of defaulters under that treatment
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schedule. The rate of default is then a combination of these two, φT δT . Al-
ternatively, other authors have considered two different rates from T to I
(rate of default) and from T to L (rate of successful treatment) [8, 9]. Al-
though either formulation involves two parameters, the interpretation seems
more direct as performed here.
Model parameters along with their typical values used herein are listed in
Table 1. Our main focus is on the parameters related to treatment, specif-
ically the average treatment length and the proportion of individuals who
drop out of treatment. These parameters will be varied to explore different
scenarios. Sensitivity to some of the other parameters will also be provided,
with all results presented for a realistic range of transmission intensities (rep-
resented by β in the model). In particular, we have concluded that the results
are quite insensible to the influence of self cure as well as TB-related death.
Therefore from now on, we consider τSC = 0 and µI = µ.
2.1. Basic analysis of the model
System (1) has one disease free equilibrium, E0 = (1, 0, 0, 0, 0) and one
endemic equilibrium, E1 = (S1, P1, L1, I1, T1). The local stability analysis of
E0 indicates that a transcritical bifurcation occurs when
βc =
µ(µ+ δ)[(µ+ τ + δT )(µ+ ω) + δT τ(1− φT )]
δ(ω + φµ)(µ+ δT )
. (2)
Indeed, for β < βc, E1 does not exists in the positive cone and E0 is stable,
while for β > βc, E0 becomes unstable and E1 exists as a stable equilibrium.
The critical value of the effective contact rate βc corresponds to the epidemic
threshold, i.e., the minimal transmission potential required for the persistence
of infection.
The same result can be express in terms of the basic reproduction number
R0, considering that the threshold condition for endemicity corresponds to
R0 = 1, with the disease dying out if R0 < 1, and becoming endemic if
R0 > 1. Applying to model (1) the next generation matrix approach as in
[18], we obtain
R0 =
βδ(ω + φµ)(µ+ δT )
µ(µ+ δ)[(µ+ τ + δT )(µ+ ω) + δT τ(1 − φT )]
. (3)
The coordinates of E1 are shown in Appendix A; I1 is the positive real
root of the polynomial that exists for R0 > 1, when the disease becomes
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endemic. Due to the relevant effect of reinfection on our analysis, we calcu-
late the reinfection threshold (RT) as in [16, 19, 20], further details of the






(µ+ τ + δT )µ+ δT τ(1 − φT )
(µ+ τ + δT )(µ+ ω) + δT τ(1− φT )
(= RRT0 ). (4)
Note, in particular, that for very small values of ω this is close to the classical
RT attained at R0 = 1/σ. Moreover, when σ is close to zero the value of R0
at which RT is attained goes to infinity (RRT0 → ∞).
3. Evaluation of different treatment regimens
Our aim is to explore how disease spread is affected by the shortening
of treatment regimens, whether this comes alone or linked to a change in
the default proportion. The two key parameters are the inverse of treatment
length and the proportion of defaulters, respectively represented in the model
by δT and φT . The analysis is set to investigate how this impact depends
on intensity of transmission as captured by the baseline R0, the composite
parameter given by (3). Although ranges of R0 are obtained by varying the
effective contact rate β in the model, we chose to present the results in terms
of R0 to benefit from its dimensionless nature and clear interpretation. As
the value of R0 itself is subjected to change as new treatment regimens are
introduced, we denote its baseline value by Rbase0 and its value under new
treatments by Rnew0 .
We assume baseline values for δT and φT and assess how modifying these





where Ibase is the proportion of infectious individuals at equilibrium with the
baseline parameter values, while Inew indicates the equilibrium proportion of
infectious individuals after the parameters have changed to describe a new
treatment regimen. Note that the values of E depend on R0 through Ibase
and Inew, as it is shown in Appendix A. Moreover, note that for a fixed Ibase,
effectiveness E is maximum when the intervention is able to eliminate the
disease (Inew = 0) and is null or negative when intervention does not reduce
TB incidence (Inew ≥ Ibase).
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Results are presented in two subsections. First, the analysis is performed
in terms of the default proportion and inverse treatment length (φT and
δT ), by varying one parameter and keeping the other fixed. Second, we
set up a family of functions relating these parameters φT (δT ), termed as
default functions. We then perform the analysis of E taking into account
the proposed functional dependence. For both cases, we point out how the
results are related to the reinfection threshold.
3.1. Sensitivity to default proportion and treatment length
By assigning different values to δT and φT independently, it is possible
to analyze how the dynamics of TB transmission depends on the treatment
lenght and default parameters when these are assumed to be uncorrelated.
In particular, we focus on the effects of changing treatment regimen as man-
ifested as follows: (i) change in disease prevalence, measured by the effec-
tiveness function E, in terms of Rbase0 ; (ii) dependence of R0 expression on
treatment parameters φT and δT .
Figure 2(a) comparatively shows prevalence curves for active TB with
baseline parameters (bold gray), reduced treatment length (dashed black),
and reduced default proportion (solid black). For illustration, we choose as
baseline values 1/δT = 1/2 yr and φT = 0.05, according to [21]. As expected,
a decrease in treatment default leads to reduction in active TB prevalence for
any value of Rbase0 . Reducing the treatment length, on the other hand, tends
to increase active TB prevalence for higher values of Rbase0 . This behavior
is better observed in Figure 2(b) that shows the corresponding effectiveness
functions E on Rbase0 . When treatment default is reduced (solid line), E is
positive and peaks near the reinfection threshold (vertical dotted line), when
the reduction of TB prevalence is more noticeable. Shortening treatment, on
the contrary, leads to negative values of E above the reinfection threshold
(dashed line), indicating that an increase in TB prevalence may result.
The relevant role of reinfection is evident when we compare panels (a)
and (b) (σ = 0.5) with panels (c) and (d) of Figure 2, for which there is no
reinfection (σ = 0). In this latter case, although reducing treatment default
still reduces TB prevalence, there is no longer a peak on the effectiveness
function, and E becomes a monotonic decreasing function (solid black lines
in panels (c)-(d)). Furthermore, when only treatment length is reduced there
is virtually no change on disease prevalence and E ≈ 0 (dashed lines). This
suggests that assumptions about protection from reinfection while individuals
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are under treatment are likely to be important determinants for the outcomes
of alternative treatment regimens.
Consistent results are obtained if we analyze the dependence of R0 ex-
pression on treatment parameters φT and δT . These can be confirmed by
inspection on the following partial derivatives:
∂R0
∂φT
= Γ0δT (µ+ δT ), (6)
∂R0
∂δT




µ(µ+ δ) [(µ+ ω)(δT + τ + µ) + τδT (1− φT )]
2
.
Both derivatives are positive, since all model parameters are positive. The
positive sign in (6) clearly corresponds to the expectations of reducing R0 as
φT is reduced. However, the positive sign in (7) is puzzling, as it suggests
that more time under treatment (smaller δT ) would be preferable.
We can understand better these results by looking into the interpreta-
tion of R0 in terms of the contribution of individuals under treatment to
the average infectious period. These individuals are not infectious but they
can go back to the infectious state without further contact with infectious
individuals: directly by default or by relapse after successful recovery (see
Figure 1). In Appendix C, we show that the derivatives of R0 (equations (6)
and (7)) are related to these two phenomena (see (C.2) and (C.3)). Hence,
we can show that when decreasing φT , there is a shift from the decreasing
contribution through default to the increasing contribution through reactiva-
tion. Overall, the infectious period decreases since the first effect is stronger,
decreasing R0, which explains the positive sign in (6). However, when treat-
ment length decreases (increasing δT ), there is an increase in the contribution
of both paths, as the time spent in T is shorter, increasing the infectious pe-
riod, which leads to the positive sign in (7) (see further details in Appendix
C).
In order to obtain a more informative approach to discuss the effect of
treatment length and default, the next section considers a dependence be-
tween the two parameters φT and δT [3] and analyzes the combined effects.
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3.2. Dependence between default proportion and treatment length
Now we assume that the proportion of defaulters is not independent of
the prescribed treatment length, and proceed to investigate how a default
function φT (δT ) leads with the conflicting effects described above.
Let us consider the total derivative of R0 in relation to δT
dR0
dδT






. Treatment shortening leads to a reduction in R0 when the




, ∀δT > 0, (9)
which is to say that a decrease in the treatment length can only lead to a
decrease in R0 if combined with a sufficiently large decrease on the default
proportion.
From these considerations we now impose a positive impact on R0, i.e.,
dR0/dδT < 0 to set up a family of default functions. By integrating both
sides of (9) from a certain δ∗T > 0 for which φT (δ
∗
T ) = φ
∗


















T ). This inequal-
ity provides a more concrete idea of the many possible functions that meet
condition (9). We want to consider functions that also verify the following
conditions:




The first condition sets up δ1 as the maximum value until which the propor-
tion φT assumes its maximum value 1, and the second assures that instanta-
neous treatments result in no default. Based on the expression obtained in
(10) we consider a simple family of default functions








From now on, we study the impact on TB prevalence by modifying the treat-
ment length and proportion of defaulters according to this default function,
which obeys both inequality (10) and conditions (i)-(ii). Other functions
obeying these conditions would lead to similar results but, in the interest
of concreteness, we proceed to estimate parameters δ1 and ∆ by fitting the
default function (11) to data obtained from the Portuguese TB Surveillance
System (SVIG-TB) for the period 2002-2009. From this dataset, which in-
cluded predicted treatment length and outcome of TB patients (Table 2),
we were able to extract default proportions of 5.99%, 4.80% and 2.44% for
prescribed treatment lengths of 12, 9 and 6 months, respectively. The rate
of treatment incompleteness (refereed to as rate of default in this study) was
calculated by pooling together cases of default and treatment failure. Note,
in particular, that the proportion of defaulters decreases with the prescribed
treatment length, consistently with the family of default functions adopted
here.
The most common predicted treatment lengths are 6, 9 and 12 months.
Using only these three points makes the analysis of φT (δT ) somewhat limited.
Nevertheless, we used a Gauss-Newton algorithm to calculate the curve that
best-fits the data according to the least-squares criteria. The values of the
parameters that minimize the residual sum of squares are of δ1 = 0.2188
yr−1 and ∆ = 0.1677 yr−1. Using the parameterized default function, we
calculated a predicted default rate of 6.14%, 4.38%, 2.79% and 0.88% for
treatment lengths of 12, 9, 6 and 2 months, respectively. Figure 3 shows the
resulting function with parameter values δ1 = 0.2188 yr
−1 and ∆ = 0.1677
yr−1. The small number of data points in Figure 3 may rise a conjecture
that they could be adjusted by a simple linear function with a negative slope.
However, we emphasize that satisfying the condition expressed by equation
(9) was the adopted guideline to obtain the explicit functional dependence
between φT and δT . We refer to this question in more detail in Appendix E.
Figure 4 shows an analysis based on TB prevalence and effectiveness
function E as previously presented in Figure 2, now changing simultaneously
treatment duration and treatment default according to the parameterized
default function and shown in Figure 3. Four treatment lengths and cor-
responding treatment defaults are considered: 2, 6, 9 and 12 months with
0.88%, 2.79%, 4.38% and 6.14% treatment default, respectively. We compare
effectiveness of a decrease in treatment length from 12 to 9, 9 to 6 and from
6 to 2 months (dotted, dashed and solid lines in panel (b)). The reduction
in treatment length and treatment default simultaneously leads to a slight
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decrease in TB prevalence for low to moderate transmission levels. The posi-
tive impact on the reduction of TB prevalence decreases from the reinfection
threshold (dotted vertical line) to higher values of Rbase0 . For high transmis-
sion levels, there is a value of Rbase0 above which the change in treatment
regimen results in a slight increase on the disease prevalence. This negative
impact for higher transmission rates becomes more evident when looking to
the effectiveness function (E < 0 in panel (b)). When transmission is suffi-
ciently intensive, even the increase in treatment adherence and consequent
decrease of the directly infected proportion of the population, cannot com-
pensate the overall enhancement of TB dissemination by reinfection, due to
faster recovery from treatment.
As we stressed before, we chose a particular function that decreases R0
and that corresponds to a positive correlation between decrease of treatment
duration and proportion of default, according to the Portuguese dataset. A
more general picture is drawn in Figure 5, where we superimpose the con-
tours of equilibrium TB prevalence (per 100,000, I(δT , φT )×100, 000), on the
parameter space (δT , φT ), with the particular default function (gray curves,
φT (δT )). Below the reinfection threshold (panel (a)), the contours are almost
flat so even a slightly decreasing function would have the benefit of reducing
disease prevalence. Above the reinfection threshold a steeper default function
would be required to this effect (panel (b)). As as example, for Rbase0 = 3.2
(referring to β = 250 yr−1) a decrease from six to two months treatment
(from δT = 2 yr
−1 to δT = 6 yr
−1) would lead to an increase in prevalence
for the parameterized default function.
Our results depend on the assumption that individuals under treatment
(class T) are in a pseudo-quarantine state, they are neither infectious nor sus-
ceptible to reinfection. Shortening this state has the potential to increase TB
prevalence, specially in regions where transmission intensity is already high
(above the reinfection threshold). In Appendix D, we extend our model in
order to accommodate different assumptions on infectiousness/susceptibility
of individuals under treatment. If they are assumed partially infectious, fol-
lowing Salomon et al. [8], shortening treatment becomes more beneficial in
terms of reducing disease prevalence, but the impact still decreases for hight
transmission where reinfection becomes more frequent. If class T is subject
to reinfection (with the same partial protection as latent individuals), as in
Abu Raddad et al. [9], then the detrimental effect of treatment shorten-
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ing in terms of increasing disease prevalence for higher endemicities is not
as pronounced, since both classes T and L are subject to reinfection. If
treatment duration and proportion of defaulters are reduced simultaneously
as informed by the Portuguese dataset, treatment shortening only results
in increased disease prevalence for very high transmission scenarios. The
qualitative behavior is the same as that described in Figure 4(b).
Other modeling studies have considered other values for δ [21] as well as
non-zero self cure (τSC) and TB-related death (µI−µ) [22, 23, 24]. Sensitivity
to these parameters shows that the qualitative behavior described in this
paper is preserved (Appendix E).
4. Discussion and conclusions
The epidemiological consequences of introducing shorter regimens to treat
active tuberculosis have been previously addressed by elaborated mathemat-
ical models [8, 9]. Here we use a minimal model structure where only the
main disease mechanisms are present, to gain mathematical tractability while
keeping comparability with more detailed studies. We explore, systemati-
cally, the effects of varying treatment length and compliance under different
epidemiological scenarios as represented by the basic reproduction number
(Rbase0 ).
Consistent among the various studies is the conviction that shorter treat-
ment regimens are likely to be associated with increased compliance, and this
duality is likely to reduce TB prevalence. We suggest, in this work, a family
of default functions to make evidence of this duality. We use data from TB
surveillance in Portugal to set up parameter values. Other datasets, such as
one from the Netherlands that refers to different treatments lengths [15], may
also be considered and most likely lead to variation in parameter estimates.
What is unique to the present study is that we do not necessarily assume an
increase in compliance as an effect of shortening prescribed treatment length
but, instead, these two parameters can be varied independently. We find that
shortening treatment alone is not expected to reduce TB prevalence, indicat-
ing the necessity of complementation with increased compliance. Intuitively,
this follows from the fact that reducing only treatment duration and keeping
the fraction of defaulters fixed, implies an increased rate out of the treatment
class T into the latent class L by successfull treatment ((1−φT )δT ), but also
increases an increase in the rate of defaulting, from T to I (φT δT ). Implicit
in previous model formulations is that only the rate from T to L is increased
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in a controlled manner by reducing treatment duration, making it difficult
to systematically trace the default fraction (see [8, 9]).
Another advantage of our analysis is the possibility of exploring different
epidemiological scenarios instead of focusing on a particular region. By vary-
ing the values of our model parameter β (linearly related to Rbase0 ) we analyze
these effects for low, moderate and high transmission intensities as well as
how they change near the reinfection threshold [20]. This finding has im-
portant practical relevance given the wide range in tuberculosis transmission
intensities across the globe, with some regions below and others above the re-
infection threshold [21] as informed by analysis of molecular typing data [25].
Our results show that the effectiveness of changing treatment length and/or
default proportion is highly sensitive to the epidemiological background.
One important assumption we make is that individuals in compartment
T are neither infectious nor subject to reinfection, which is not an universal
assumption in the tuberculosis literature. We relax this assumption (details
in Appendix E) and consider the cases for which individuals under treatment
are partially susceptible to reinfection as in [9] or partially infectious as in
[8]. The qualitative behavior is not changed but the effectiveness of reduc-
ing treatment length is enhanced when considering that individuals under
treatment are infectious until the end of treatment.
We summarize our results based on active TB prevalence and effectiveness
function E in three cases:
a) Reducing treatment default, for fixed treatment length, leads to pos-
itive effectiveness (reduction in disease prevalence) for low, moderate
and high transmission intensities, with the highest impact near the
reinfection threshold.
b) Reducing treatment length, for fixed treatment default, leads to nega-
tive effectiveness (increase in disease prevalence) for high transmission
intensities (above the reinfection threshold), as this shortens the period
of time when individuals are under treatment and therefore not subject
to reinfection.
c) Assuming a combined scenario with a decreasing default function φT (δT )
coupling treatment default and treatment length, whose parameters are
based on data of treatment default for three different treatment length
(12, 9 and 6 months), shortening treatment may also have negative
effectiveness (increase disease prevalence) especially in regions where
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transmission intensity is already high (above the reinfection threshold).
Results are, in principle, robust to the particular choice of a default
function that adjusts the trend of decreasing default with treatment
length found in the data.
While the results relative to reducing treatment default are intuitive,
those concerning the reduction of treatment length require further investiga-
tion into the assumptions regarding the characteristics of individuals under
treatment. Shortening treatment alone may not reduce the burden of active
TB under high transmission rates, but this is sensitive to whether a reduc-
tion in prescribed treatment length brings with it a reduction in the default
proportion. This is also depending on whether individuals under treatment
contribute to the transmission dynamics, either by being capable of infecting
or being reinfected by others. Clinical data is necessary for the develop-
ment of a smoother description of the transitions into and out of treatment,
as the effects of changing treatment regimens are so sensitive to different
assumptions that seem equally plausible and pave the literature.
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Tables
Table 1: Model parameters
symbol definition value Reference/Comment
β effective contact rate 77.3-386.6 yr−1 referring to R0 (1-5) [21]
µ death rate for noninfectious individuals 1/80 yr−1
µI death rate for infectious individuals 1/80 yr−1 assumed µI ≈ µ
δ inverse of primary infection length 12 yr−1 [16]
φ fraction of Mtb infected population developing 0.05 [27]
active TB (the 1− φ fraction remain latent)
σ factor of exogenous reinfection for latent 0.5 [25]
ω rate of endogenous reactivation for latent infections 0.0003 yr−1 [17]
τ rate at which infectious individuals enter treatment 6 yr−1 [21]
τSC rate of self-cure 0 yr−1 neglected self-cure
δT inverse of treatment length 2 yr−1 or varying [21]
φT whole fraction of individuals that drop out treatment 0.05 or varying [21]
(the 1− φT fraction are successfully treated)
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Table 2: Outcome of TB treatment in Portugal for different predicted treatment lengths.
predicted δT 1 yr
−1 4/3 yr−1 2 yr−1
completed 877 (83.44%) 3546 (88.67%) 5722 (93.16%)
failure 4 (0.38%) 11 (0.28%) 4 (0.07%)
defaults 59 (5.61%) 181 (4.53%) 146 (2.38%)
death 111 (10.56%) 261 (6.53%) 270 (4.40%)
total 1051 (100.00%) 3999 (100.00%) 6142 (100.00%)
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Figure captions
Figure 1: Tuberculosis model. Individuals are classified according to disease history into
susceptible (S), primary infected (S), latent (L), infectious (I), or under treatment (T).
Parameters are described in Table 1. The force of infection is represented by βI(t), where
β is the efficient contact rate.
Figure 2: Dependence of equilibrium infectious proportion I (a) on R0. The heavy gray
curve corresponds to the baseline scenario with treatment duration of six months (δT = 2
yr−1) and treatment failure of 5% (φT = 0.05). Dashed and thin solid black curves corre-
spond to a change in treatment duration to two months (δT = 6 yr
−1) and in treatment
failure to 1% (φT = 0.01), respectively. (b) Dependence of the effectiveness function E on
R0 when decreasing treatment length from six to two months (dashed black curves) and
when decreasing treatment default from 5% to 1% (light full black line). The reinfection
threshold for the baseline values of parameters φT and is marked by the vertical dotted
line. A similar analysis of Figures (a) and (b) assuming σ = 0 is presented in (c) and
(d) respectively.
Figure 3: Default function φT (δT ), given by (11). Using the Portuguese dataset, the
parameter values for the default function (11) are: δ1 = 0.2188 yr
−1 and ∆ = 0.1677 yr−1.
Data on treatment default for predicted treatment length are marked by open circles ◦.
Figure 4: (a) Equilibrium curve for the proportion of infectious: light solid curve, bold gray
curve, dashed and dotted curves correspond to treatment duration of 2, 6, 9 and 12 months
and treatment default of 0.88%, 2.79.15%, 4.38% and 6.14%, respectively, according to the
default function given by (11) with parameter values δ1 = 0.2188 yr
−1 and ∆ = 0.1677
yr−1. (b) Effectiveness of decreasing treatment length and default proportion from: 12 to
9 months that corresponds to 6.14% to 4.38% (dotted line); 9 to 6 months that corresponds
to 4.38% to 2.79% (dashed line); from 6 to 2 months that corresponds to 2.79% to 0.88%
(solid line). The reinfection threshold is marked by the vertical dotted line.
Figure 5: Contour plot for the infectious prevalence per 100 000 at equilibrium when vary-
ing δT (inverse of treatment duration) and φT (proportion default), for different transmis-
sion scenarios R0 = 1.9 and 3.9 (below and above the reinfection threshold). Gray curves
correspond to the default function φT (δT ) adjusted to data.
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Figure 6: Dependence of the effectiveness function E on R0, when varying the treatment
length δT , for the three different assumptions on the under treatment class: not infectious
neither susceptible to reinfection (solid curves); partially infectious (dashed curves) as
in [8], and partially susceptible to reinfection (gray curves) as in [9]. (a) Case where
treatment duration is reduced from six months to two months and treatment default is
5% (δT = 2 yr
−1 to δT = 6 yr
−1, φT = 0.05) for all three scenarios. (b) Effectiveness
curves when treatment duration is reduced from six months to two months and treatment
default is 5% for different levels of infectiousness: θ = 0.25, 0.1, 0.05, 0.01 and 0. (c)
Case where treatment length and treatment default are reduced simultaneously, from six
months to two months and from 5% to 1%. (δT = 2 yr
−1 to δT = 6 yr
−1 and φT = 0.05
to φT = 0.01).
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Appendix A. Equilibrium equations
System (1) has one disease free equilibrium, E0 = (1, 0, 0, 0, 0) and one
endemic equilibrium, E1 = (S1, P1, L1, I1, T1). The coordinate of E1 are
expressed in terms of the positive root of a second order polynomial
a2(R0)I
2



















a0(R0) = B(1− R0)
where A = (µ+δφ)(µ+δT+τ)+δT τ(1−φT ), B = µ(µ+δ)[(µ+ω)(µ+δT+τ)+
δT τ(1− φT )] and C = δ(ω+ φµ)(µ+ δT ) and the basic reproduction number
R0. In (A.1), we stress the dependency of ai on R0 as this is the parameter
most directly related to disease spreading. Finally, I1 is the positive real root
of the polynomial that exists for R0 > 1, when the disease becomes endemic.
Appendix B. Reinfection threshold
Following Rodrigues [26], the reinfection sub-model, where the population
is considered to be partially immunized and infection processes other then
reinfection are removed (ω = 0) is represented by the following system of






















= σβIL− (δ + µ)P
dL
dt
= µ+ (1− φ)δP + (1− φT )δTT − σβIL− µL
dI
dt
= φδP + φT δTT − (τ + µ)I
dT
dt
= τI − (δT + µ)T
. (B.1)
System (B.1) has one disease free equilibrium, e0 = (0, 1, 0, 0) and one en-
demic equilibrium, e1 = (P
∗, L∗, I∗, T ∗) where the coordinates can be derived
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σβ((µ+ δφ)(µ+ δT + τ) + δT τ(1− φT ))
. (B.2)





(δ + µ)[µ(δT + τ + µ) + (1− φT )δT τ ]
φδ(µ+ δT )
Indeed, for β < βRT , e1 does not exists in the positive cone and e0 is stable,
while for β > βRT , e0 becomes unstable and e1 exists as a stable equilib-
rium. The critical value of the effective contact rate βRT corresponds to the
invasion threshold [19], i.e., the minimal transmission potential required for
the persistence of reinfection and it marks a change in the behavior of the






(µ+ τ + δT )µ+ δT τ(1 − φT )
(µ+ τ + δT )(µ+ ω) + δT τ(1− φT )
(= RRT0 ).
Appendix C. Interpretation of R0 in relation to treatment







where Γ1 is given by the transmission rate times the average fraction surviving












The factor 1/[(τ + µ)(1 − A)] is equivalent to the average infectious period
















Note that A1 and A2 take into account the two possible paths from T back
to I:




b) by relapsing back to the infectious class after recovering to the latent




















completing the derivation of (C.1).






































Now, we can infer the behaviour of R0 relative to φT and δT by analysing
the contribution of individuals in class T to the infectious period. When
treatment default (φT ) decreases, there is a shift from the contribution through
default (A1), which decreases, to the contribution through reactivation, which
increases (A2). We can check by the following derivatives that the first effect























































However, when treatment length decreases, there is an increase in the con-































Appendix D. The compartment of under treatment individuals in
TB models
We consider a more general model that can accommodate different as-
sumptions for the infectiousness/susceptibility of under treatment class T,






























= µ− λS − µS
dP
dt
= λ(S + σL+ σTT )− (δ + µ)P
dL
dt
= (1− φ)δP + (1− φT )δTT − σλL− (ω + µ)L
dI
dt
= φδP + ωL+ φT δTT − (τ + µ)I
dT
dt
= τI − σTλT − (δT + µ)T
, (D.1)
where λ = β(I + θT ) for θ ∈ [0, 1] and σT ∈ [0, 1].
We consider three possible scenarios:
a) for λ = βI (θ = 0), σT = 0, individuals under treatment are neither
infectious nor susceptible to reinfection, system (D.1) corresponds to a
simplified version of system (1), with µI = µ and τSC = 0;
b) for λ = βI and σT = σ, individuals under treatment are assumed
susceptible to reinfection with partial protection similar to latent indi-
viduals as in [9];
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c) finally, for λ = β(I + θT ) and σT = 0 individuals in class T are
considered partially infectious, as in [8], parameter θ ∈ [0, 1] controls
infectiousness of individuals under treatment.
For all scenarios, system (D.1) has two possible equilibria: a disease free
and an endemic equilibrium. We compare the endemic equilibria and the cor-
respondent effectiveness function E, under the three assumptions described
above. If only the duration of treatment is changed from six (δT = 2 yr
−1)
to two months (δT = 6 yr
−1) then treatment effectiveness is null or negative
when assuming that individuals under treatment are not infectious (see Fig-
ure 6 (a) full and dotted lines). However, when individuals in class T are
partially infectious we only see this negative impact for very high endemic-
ities. In this case, shorter time in class T corresponds to a lower force of
infection and consequently to a lower disease level, for low endemic regions.
But faster treatment also means a faster change to a latent state where re-
infection is possible. So, when reinfection is strong, it can have a negative
impact. Figure 6 (b) shows that the behavior described above is enhanced
by infectiousness (for higher values of θ).
Finally, if we improve both treatment duration (δT = 2 yr
−1 to δT = 6
yr−1) and default (φT = 5% to φT = 1%) then all three assumptions give
similar qualitative results (see Figure 6 (c)). Again, effectiveness is higher
for the case where individuals under treatment are partially infectious.
Appendix E. Supplementary material
In the first section, a sensitivity analysis to parameter δ is done to illus-
trate how the magnitude of our results depend on this parameter.
In second section, a sensitivity analysis to parameters τSC and µI is con-
ducted to justify our choice to simplify the model and consider these param-
eters τSC = 0 and µI = µ, respectively.
Due to the small data set analysed, a simple linear fit of the data was
performed, in the third section, and the restrictions of the use of this linear
function as a default function is further discussed.
The supplementary material here described can be found online at
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